Regulation of androgen action.

Publisher Summary This chapter describes the different aspects of regulation of androgen action. Androgens belong to a class of C-19 steroids secreted primarily by the testis and adrenal cortex. Hormonally active androgens promote reproductive and anabolic functions. Both reproductive and anabolic effects of androgens are mediated by their interaction with the androgen receptor (AR), a member of the steroid-thyroid hormone-retinoid-vitamin D superfamily of nuclear receptors (NRs) that function as ligand-activated transcription factors. Almost all of the androgen functions, except its conversion to estrogen by the enzyme aromatase in certain target cells are known to be mediated by the androgen receptor. The androgen receptor are coded by a single copy gene, which is located on the X chromosome. The functional relevance of the segmented domain structure of the NR superfamily is supported by the results of deletion mutagenesis and domain swapping among various receptor proteins. The interaction between the amino terminal and the steroid-binding carboxy-terminal end in the AR transactivation function was initially indicated by the finding that a segment within the hormone-binding domain exerts an inhibitory influence in the transcription regulatory activity of the AR, and the deletion of this region results in ligand-independent activation of the receptor.

[1]  P. Webb,et al.  Characterization of response elements for androgens, glucocorticoids and progestins in mouse mammary tumour virus. , 1988, Nucleic acids research.

[2]  C. Hänni,et al.  Ligand binding was acquired during evolution of nuclear receptors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[3]  A. Takeshita,et al.  Molecular cloning and properties of a full-length putative thyroid hormone receptor coactivator. , 1996, Endocrinology.

[4]  J. Polman,et al.  ERβ: Identification and characterization of a novel human estrogen receptor , 1996 .

[5]  J. Wilson,et al.  Characterization and expression of a cDNA encoding the human androgen receptor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[6]  L. Freedman Anatomy of the steroid receptor zinc finger region. , 1992, Endocrine reviews.

[7]  E. Wilson,et al.  Domain functions of the androgen receptor , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[8]  Peter Goodfellow,et al.  "Male Development of Chromosomally Female Mice Transgenic for Sry gene" (1991), by Peter Koopman, et al. , 2014 .

[9]  R. Matusik,et al.  Characterization of two cis-acting DNA elements involved in the androgen regulation of the probasin gene. , 1993, Molecular endocrinology.

[10]  A. Roy Regulation of Steroid Hormone Action in Target Cells by Specific Hormone-Inactivating Enzymes , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[11]  B. Oostra,et al.  Trinucleotide (GGN) repeat polymorphism in the human androgen receptor (AR) gene. , 1993, Human molecular genetics.

[12]  G. Jenster,et al.  Nuclear import of the human androgen receptor. , 1993, The Biochemical journal.

[13]  T. H. van der Kwast,et al.  Domains of the human androgen receptor involved in steroid binding, transcriptional activation, and subcellular localization. , 1991, Molecular endocrinology.

[14]  Russell,et al.  Molecular genetics and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 deficiency. , 1996, The Journal of clinical endocrinology and metabolism.

[15]  K. Burnstein,et al.  Two androgen response elements in the androgen receptor coding region are required for cell-specific up-regulation of receptor messenger RNA. , 1996, Molecular endocrinology.

[16]  F. S. French,et al.  A complex response element in intron 1 of the androgen-regulated 20-kDa protein gene displays cell type-dependent androgen receptor specificity. , 1993, The Journal of biological chemistry.

[17]  S. Yen,et al.  The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women. , 1990, The Journal of clinical endocrinology and metabolism.

[18]  Chawnshang Chang,et al.  Molecular cloning of human and rat complementary DNA encoding androgen receptors. , 1988, Science.

[19]  E. Wilson,et al.  Androgen Receptor Antagonist versus Agonist Activities of the Fungicide Vinclozolin Relative to Hydroxyflutamide (*) , 1995, The Journal of Biological Chemistry.

[20]  F. S. French,et al.  Response elements of the androgen-regulated C3 gene. , 1992, The Journal of biological chemistry.

[21]  F. S. French,et al.  Transcriptional activation and nuclear targeting signals of the human androgen receptor. , 1991, The Journal of biological chemistry.

[22]  G. Jenster,et al.  A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. , 1990, Biochemical and biophysical research communications.

[23]  J. Trapman,et al.  The rat androgen receptor gene promoter , 1990, Molecular and Cellular Endocrinology.

[24]  S. Yeh,et al.  Identification of 3',5'-cyclic adenosine monophosphate response element and other cis-acting elements in the human androgen receptor gene promoter. , 1994, Molecular endocrinology.

[25]  C. Chang,et al.  Induction of translation by the 5'-untranslated region of human androgen receptor mRNA. , 1994, The Journal of biological chemistry.

[26]  E. Wilson,et al.  The androgen receptor: an overview. , 1994, Recent progress in hormone research.

[27]  R. Brenner,et al.  Steroid hormone receptors in the adrenal glands of fetal and adult rhesus monkeys. , 1992, The Journal of clinical endocrinology and metabolism.

[28]  F. S. French,et al.  Sequence of the intron/exon junctions of the coding region of the human androgen receptor gene and identification of a point mutation in a family with complete androgen insensitivity , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[29]  U. Fuhrmann,et al.  Stable transfection of androgen receptor and MMTV-CAT into mammalian cells: Inhibition of cat expression by anti-androgens , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[30]  X. Cai,et al.  Genes regulated by androgen in the rat ventral prostate. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[31]  S. Liao,et al.  Structural analysis of complementary DNA and amino acid sequences of human and rat androgen receptors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[32]  G. Rouleau,et al.  Reduced transcriptional regulatory competence of the androgen receptor in X–linked spinal and bulbar muscular atrophy , 1993, Nature genetics.

[33]  C. Allis,et al.  Steroid receptor coactivator-1 is a histone acetyltransferase , 1997, Nature.

[34]  A Jost,et al.  Hormonal factors in the sex differentiation of the mammalian foetus. , 1970, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[35]  R. Miesfeld,et al.  Functional characterizations of the androgen receptor confirm that the molecular basis of androgen action is transcriptional regulation. , 1990, Molecular endocrinology.

[36]  J. Simard,et al.  Molecular basis of human 3β-hydroxysteroid dehydrogenase deficiency , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[37]  H. Klocker,et al.  Androgen Receptor-Ets Protein Interaction Is a Novel Mechanism for Steroid Hormone-mediated Down-modulation of Matrix Metalloproteinase Expression* , 1996, The Journal of Biological Chemistry.

[38]  D. Tindall,et al.  The mouse androgen receptor gene contains a second functional promoter which is regulated by dihydrotestosterone. , 1994, Biochemistry.

[39]  F. Ghadessy,et al.  Long polyglutamine tracts in the androgen receptor are associated with reduced trans-activation, impaired sperm production, and male infertility. , 1997, The Journal of clinical endocrinology and metabolism.

[40]  V. Mahesh,et al.  Autoregulation of androgen receptor in rat ventral prostate: involvement of c-fos as a negative regulator , 1996, Molecular and Cellular Endocrinology.

[41]  J. Gustafsson,et al.  Interaction of the human androgen receptor transactivation function with the general transcription factor TFIIF. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[42]  R. Evans,et al.  Nuclear Receptor Coactivator ACTR Is a Novel Histone Acetyltransferase and Forms a Multimeric Activation Complex with P/CAF and CBP/p300 , 1997, Cell.

[43]  B. O’Malley,et al.  Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor Superfamily , 1995, Science.

[44]  W. Odell,et al.  Control of adrenal androgen secretion. , 1980, Endocrine reviews.

[45]  S. Liao,et al.  Selective Retention of Dihydrotestosterone by Prostatic Nuclei , 1968, Nature.

[46]  B. O’Malley,et al.  Molecular interactions of steroid hormone receptor with its enhancer element: Evidence for receptor dimer formation , 1988, Cell.

[47]  Andrew J. Bannister,et al.  The CBP co-activator is a histone acetyltransferase , 1996, Nature.

[48]  O. Jänne,et al.  Analysis of androgen receptor-DNA interactions with receptor proteins produced in insect cells. , 1994, The Journal of biological chemistry.

[49]  E. A. Thompson,et al.  STUDIES ON THE AROMATIZATION OF C‐19 ANDROGENS * , 1973, Annals of the New York Academy of Sciences.

[50]  P. Sheridan At the cutting edge can a single androgen receptor fill the bill? , 1991, Molecular and Cellular Endocrinology.

[51]  K. Horwitz,et al.  Nuclear receptor coactivators and corepressors. , 1996, Molecular endocrinology.

[52]  Thorsten Heinzel,et al.  Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor , 1995, Nature.

[53]  K. Korach,et al.  Effect of testosterone and estradiol in a man with aromatase deficiency. , 1997, The New England journal of medicine.

[54]  Y. Furuya,et al.  The role of androgen in the regulation of programmed cell death/apoptosis in normal and malignant prostatic tissue. , 1994, Seminars in cancer biology.

[55]  S. Yen,et al.  Circulating concentrations of dehydroepiandrosterone and dehydroepiandrosterone sulfate during puberty. , 1975, The Journal of clinical endocrinology and metabolism.

[56]  Jean D. Wilson,et al.  Androgen increases androgen receptor protein while decreasing receptor mRNA in LNCaP cells , 1991, Molecular and Cellular Endocrinology.

[57]  F. Cellotti,et al.  Anabolic steroids: A review of their effects on the muscles, of their possible mechanisms of action and of their use in athletics , 1992, The Journal of Steroid Biochemistry and Molecular Biology.

[58]  U. Drews,et al.  Regression of mouse mammary gland anlagen in recombinants of Tfm and wild-type tissues: testosterone acts via the mesenchyme , 1977, Cell.

[59]  B. Chatterjee,et al.  Molecular cloning and characterization of cDNA for androgen-repressible rat liver protein, SMP-2. , 1987, The Journal of biological chemistry.

[60]  D. Thompson,et al.  Androgen glucuronyl transferase activity in rat liver, evidence for the importance of hepatic tissue in 5 alpha-reduced androgen metabolism. , 1989, Journal of steroid biochemistry.

[61]  P. C. Supakar,et al.  Nuclear Factor B Functions as a Negative Regulator for the Rat Androgen Receptor Gene and NF-B Activity Increases during the Age-dependent Desensitization of the Liver (*) , 1995, The Journal of Biological Chemistry.

[62]  P. Riegman,et al.  The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. , 1991, Molecular endocrinology.

[63]  Thorsten Heinzel,et al.  A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear Receptors , 1996, Cell.

[64]  D. Tindall,et al.  Regulation of the 5'-flanking region of the mouse androgen receptor gene by cAMP and androgen. , 1993, Molecular endocrinology.

[65]  J. Isaacs Role of androgens in prostatic cancer. , 1994, Vitamins and hormones.

[66]  T. Penning,et al.  Molecular endocrinology of hydroxysteroid dehydrogenases. , 1997, Endocrine reviews.

[67]  W. Rosner,et al.  Estradiol Activates the Prostate Androgen Receptor and Prostate-specific Antigen Secretion through the Intermediacy of Sex Hormone-binding Globulin* , 1997, The Journal of Biological Chemistry.

[68]  B. O’Malley,et al.  Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain. , 1993, Molecular endocrinology.

[69]  Ronald J. Moore,et al.  Studies on the Mechanism of 3α-Androstanediol-Induced Growth of the Dog Prostate , 1978 .

[70]  K. Yamamoto,et al.  Signal transduction and transcriptional regulation by glucocorticoid receptor-LexA fusion proteins. , 1988, Science.

[71]  D. Tindall,et al.  Molecular mechanisms of androgen action. , 1994, Vitamins and hormones.

[72]  J. D. Wilson,et al.  Steroid 5 alpha-reductase: two genes/two enzymes. , 1994, Annual review of biochemistry.

[73]  Y. Lefebvre,et al.  Phosphorylation and nuclear processing of the androgen receptor. , 1990, Biochemical and biophysical research communications.

[74]  M. Tóth,et al.  Relative binding affinities of testosterone, 19-nortestosterone and their 5α-reduced derivatives to the androgen receptor and to other androgen-binding proteins: a suggested role of 5α-reductive steroid metabolism in the dissociation of “myotropic” and “androgenic” activities of 19-nortestosterone , 1982 .

[75]  G. Evans,et al.  Cell proliferation studies in the rat prostate: II. The effects of castration and androgen‐induced regeneration upon basal and secretory cell proliferation , 1987, The Prostate.

[76]  N. Bruchovsky,et al.  The conversion of testosterone to 5-alpha-androstan-17-beta-ol-3-one by rat prostate in vivo and in vitro. , 1968, The Journal of biological chemistry.

[77]  J. Trapman,et al.  Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor. , 1997, Biochemistry.

[78]  C. Roselli,et al.  Distribution of aromatase cytochrome P450 messenger ribonucleic acid in adult rhesus monkey brains. , 1997, Biology of reproduction.

[79]  A. Adler,et al.  Specific steroid response from a nonspecific DNA element , 1994, The Journal of Steroid Biochemistry and Molecular Biology.

[80]  E. Crawford,et al.  Orchiectomy and nilutamide or placebo as treatment of metastatic prostatic cancer in a multinational double-blind randomized trial. , 1993, The Journal of urology.

[81]  T. Ikonen,et al.  Interaction between the Amino- and Carboxyl-terminal Regions of the Rat Androgen Receptor Modulates Transcriptional Activity and Is Influenced by Nuclear Receptor Coactivators* , 1997, The Journal of Biological Chemistry.

[82]  J. M. Kim,et al.  Androgen and estrogen sulfotransferases of the rat liver: physiological function, molecular cloning, and in vitro expression. , 1994, Chemico-biological interactions.

[83]  G. Jenster,et al.  Steroid receptor induction of gene transcription: a two-step model. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[84]  C. Wilson,et al.  Regulation of immunoreactive androgen receptor in the adrenal gland of the adult rat. , 1996, Endocrinology.

[85]  S. Fawell,et al.  Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor , 1990, Cell.

[86]  E. Wilson,et al.  A ligand-dependent bipartite nuclear targeting signal in the human androgen receptor. Requirement for the DNA-binding domain and modulation by NH2-terminal and carboxyl-terminal sequences. , 1994, The Journal of biological chemistry.

[87]  J. M. Kim,et al.  A novel regulatory element associated with age-dependent expression of the rat androgen receptor gene. , 1993, The Journal of biological chemistry.

[88]  C. Wilson,et al.  A and B forms of the androgen receptor are present in human genital skin fibroblasts. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[89]  D. Tindall,et al.  Androgen induction of a human prostate-specific kallikrein, hKLK2: characterization of an androgen response element in the 5' promoter region of the gene. , 1993, Biochemistry.

[90]  E. Wilson,et al.  Transcriptional repression of the alpha-subunit gene by androgen receptor occurs independently of DNA binding but requires the DNA-binding and ligand-binding domains of the receptor. , 1997, Molecular endocrinology.

[91]  B. O’Malley,et al.  Molecular mechanisms of action of steroid/thyroid receptor superfamily members. , 1994, Annual review of biochemistry.

[92]  B. Katzenellenbogen,et al.  Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[93]  C. Labrie,et al.  Androgenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate. , 1988, Endocrinology.

[94]  J. Wilson,et al.  Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone. , 1990, Endocrinology.

[95]  R. Sharpe,et al.  Immunohistochemical localization of androgen receptors in the rat testis: evidence for stage-dependent expression and regulation by androgens. , 1994, Endocrinology.

[96]  J. Winderickx,et al.  Interaction of androgen response elements with the DNA-binding domain of the rat androgen receptor expressed in Escherichia coli. , 1991, The Journal of biological chemistry.

[97]  G. Hager,et al.  Transcription factor loading on the MMTV promoter: a bimodal mechanism for promoter activation. , 1992, Science.

[98]  S. Yeh,et al.  Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[99]  C. Olsson,et al.  Induction of the TRPM-2 gene in cells undergoing programmed death , 1989, Molecular and cellular biology.

[100]  R. Kato,et al.  Cloning and sequence analysis of a rat liver cDNA encoding hydroxysteroid sulfotransferase. , 1989, Biochemical and biophysical research communications.

[101]  Zbigniew Dauter,et al.  Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.

[102]  J. Trapman,et al.  Two different, overlapping pathways of transcription initiation are active on the TATA-less human androgen receptor promoter. The role of Sp1. , 1993, The Journal of biological chemistry.

[103]  A. Cheung,et al.  4-Azasteroidal 5 alpha-reductase inhibitors without affinity for the androgen receptor. , 1984, The Journal of biological chemistry.

[104]  K. Yamamoto,et al.  Glucocorticoid-stimulated accumulation of mouse mammary tumor virus RNA: increased rate of synthesis of viral RNA. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[105]  P. Donahoe,et al.  Müllerian inhibiting substance: gene structure and mechanism of action of a fetal regressor. , 1987, Recent progress in hormone research.

[106]  P. Sassone-Corsi,et al.  The dynamics of the transcriptional response to cyclic adenosine 3',5'-monophosphate: recurrent inducibility and refractory phase. , 1997, Molecular endocrinology.

[107]  J. Trapman,et al.  Localization and hormonal stimulation of phosphorylation sites in the LNCaP-cell androgen receptor. , 1993, The Biochemical journal.

[108]  J. Wilson,et al.  Partial characterization of the cytosol 3 alpha-hydroxysteroid: NAD(P)+oxidoreductase of rat ventral prostate. , 1975, Biochemistry.

[109]  G. Cunha,et al.  The possible influence of temporal factors in androgenic responsiveness of urogenital tissue recombinants from wild-type and androgen-insensitive (Tfm) mice. , 1978, The Journal of experimental zoology.

[110]  J. A. van der Korput,et al.  Cloning, structure and expression of a cDNA encoding the human androgen receptor. , 1988, Biochemical and biophysical research communications.

[111]  R. Matusik,et al.  Inhibition of androgen action by dehydroepiandrosterone sulfotransferase transfected in PC-3 prostate cancer cells. , 1998, Chemico-biological interactions.

[112]  B. Knebelmann,et al.  Anti-Müllerian hormone and intersex states , 1991, Trends in Endocrinology & Metabolism.

[113]  T. H. van der Kwast,et al.  Androgen receptor expression in human tissues: an immunohistochemical study. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[114]  Miguel Beato,et al.  Steroid hormone receptors: Many Actors in search of a plot , 1995, Cell.

[115]  Carolyn J. Brown,et al.  Androgen receptor locus on the human X chromosome: regional localization to Xq11-12 and description of a DNA polymorphism. , 1989, American journal of human genetics.

[116]  T. Ikonen,et al.  Mutual Transcriptional Interference between RelA and Androgen Receptor* , 1996, The Journal of Biological Chemistry.

[117]  R. Neri,et al.  Anti-androgenicity of flutamide and its metabolite Sch 16423. , 1979, Biochemical Society transactions.

[118]  P. Kushner,et al.  Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. , 1995, The EMBO journal.

[119]  D. Tindall,et al.  Identification and characterization of a suppressor element in the 5'-flanking region of the mouse androgen receptor gene. , 1994, Nucleic acids research.

[120]  W. Mckeehan,et al.  Heparin-binding keratinocyte growth factor is a candidate stromal-to-epithelial-cell andromedin. , 1992, Molecular endocrinology.

[121]  B. Howard,et al.  The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases , 1996, Cell.

[122]  R. Evans,et al.  The steroid and thyroid hormone receptor superfamily. , 1988, Science.

[123]  M. Parker,et al.  Tissue-specific and hormonal regulation of the gene for rat prostatic steroid-binding protein in transgenic mice , 1989, Molecular and cellular biology.

[124]  M. Montminy,et al.  Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133 , 1989, Cell.

[125]  B. Banaś,et al.  Analysis of the promoter of the human prostatic acid phosphatase gene. , 1994, Biochimica et biophysica acta.

[126]  B. Chatterjee,et al.  Estrogen sulfotransferase of the rat liver: complementary DNA cloning and age- and sex-specific regulation of messenger RNA. , 1992, Molecular endocrinology.

[127]  C S Song,et al.  A distal activation domain is critical in the regulation of the rat androgen receptor gene promoter. , 1993, The Biochemical journal.

[128]  A. Thompson,et al.  Oestrogen sulfotransferase: molecular cloning and sequencing of cDNA for the bovine placental enzyme. , 1988, Australian journal of biological sciences.

[129]  E. Wilson,et al.  Steroid requirement for androgen receptor dimerization and DNA binding. Modulation by intramolecular interactions between the NH2-terminal and steroid-binding domains. , 1993, The Journal of biological chemistry.

[130]  K. Umesono,et al.  Determinants of target gene specificity for steroid/thyroid hormone receptors , 1989, Cell.

[131]  S. Liao,et al.  Inhibition of steroid 5 alpha-reductase by specific aliphatic unsaturated fatty acids. , 1992, The Biochemical journal.

[132]  M. Beato,et al.  Hormone induces binding of receptors and transcription factors to a rearranged nucleosome on the MMTV promoter in vivo. , 1995, The EMBO journal.

[133]  V. Toscano,et al.  Effects of dihydrotestosterone treatment on adrenal gland function and morphology in adult female guinea-pigs. , 1990, Journal of steroid biochemistry.

[134]  E. Orwoll,et al.  Transcriptional up-regulation of the human androgen receptor by androgen in bone cells. , 1997, Endocrinology.

[135]  J. Green,et al.  Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[136]  K. Korach,et al.  Estrogenic responses in estrogen receptor-alpha deficient mice reveal a distinct estrogen signaling pathway. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[137]  Immunohistochemical analysis of androgen effects on androgen receptor expression in developing Leydig and Sertoli cells. , 1997, Endocrinology.

[138]  R. Lockshin,et al.  Expression of clusterin in cell differentiation and cell death. , 1994, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[139]  R. Hiipakka,et al.  Androgen receptors: structures, mutations, antibodies and cellular dynamics. , 1989, Journal of steroid biochemistry.

[140]  J. A. van der Korput,et al.  The human androgen receptor: domain structure, genomic organization and regulation of expression. , 1989, Journal of steroid biochemistry.

[141]  J. Wilson,et al.  Androgen abuse by athletes. , 1988, Endocrine reviews.

[142]  H. Ponta,et al.  The hormone response element of the mouse mammary tumour virus DNA mediates the progestin and androgen induction of transcription in the proviral long terminal repeat region. , 1987, The EMBO journal.

[143]  M. Parker,et al.  A consensus DNA-binding site for the androgen receptor. , 1992, Molecular endocrinology.

[144]  E. Fuchs,et al.  Keratinocyte growth factor is required for hair development but not for wound healing. , 1996, Genes & development.

[145]  M. Tsai,et al.  Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes. , 1997, Cancer research.

[146]  J. Grootegoed,et al.  Transient down-regulation of androgen receptor messenger ribonucleic acid (mRNA) expression in Sertoli cells by follicle-stimulating hormone is followed by up-regulation of androgen receptor mRNA and protein. , 1992, Endocrinology.

[147]  R. Winneker,et al.  Studies on the mechanism of action of Win 49596: a steroidal androgen receptor antagonist. , 1989, Journal of steroid biochemistry.

[148]  J. Trapman,et al.  Characterization of the human androgen receptor transcription unit. , 1991, The Journal of biological chemistry.

[149]  F. S. French,et al.  Specificity of ligand-dependent androgen receptor stabilization: receptor domain interactions influence ligand dissociation and receptor stability. , 1995, Molecular endocrinology.

[150]  B. Chatterjee,et al.  Tissue-specific and Androgen-repressible Regulation of the Rat Dehydroepiandrosterone Sulfotransferase Gene Promoter* , 1998, The Journal of Biological Chemistry.

[151]  J. Trapman,et al.  Androgen regulation of the rat keratinocyte growth factor (KGF/FGF7) promoter. , 1996, Biochemical and biophysical research communications.

[152]  K. Kratochwil,et al.  Tissue interaction in androgen response of embryonic mammary rudiment of mouse: identification of target tissue for testosterone. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[153]  R. Matusik,et al.  Prostate cancer in a transgenic mouse. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[154]  P. C. Supakar,et al.  Role of transcription factors in the age-dependent regulation of the androgen receptor gene in rat liver. , 1996, Biological signals.

[155]  C. Lengel,et al.  Cloning and characterization of the promoter region of the human keratinocyte growth factor gene , 1995, The Journal of Biological Chemistry.

[156]  A. Ray,et al.  Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[157]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[158]  H. Towle,et al.  Identification of nuclear factors that enhance binding of the thyroid hormone receptor to a thyroid hormone response element. , 1989, Molecular endocrinology.

[159]  M. Coyne,et al.  Relation of the testis to adrenal enzyme activity and adrenal corticosterone production in the rat. , 1966, Endocrinology.

[160]  J. Trapman,et al.  The mouse androgen receptor. Functional analysis of the protein and characterization of the gene. , 1991, The Biochemical journal.

[161]  Jian Wang,et al.  Androgen and Glucocorticoid Receptor Heterodimer Formation , 1997, The Journal of Biological Chemistry.

[162]  Bruce Gottlieb,et al.  The androgen receptor gene mutations database , 1996, Nucleic Acids Res..

[163]  Nicholas Bruchovsky,et al.  Control of tumor progression by maintenance of apoptosis , 1996, The Prostate. Supplement.

[164]  C. Chang,et al.  Regulation of androgen receptor mRNA in rat Sertoli and peritubular cells. , 1991, Biology of reproduction.

[165]  M. Mancini,et al.  Targeted overexpression of androgen receptor with a liver-specific promoter in transgenic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[166]  M. Shago,et al.  Inhibition of nuclear hormone receptor activity by calreticulin , 1994, Nature.

[167]  H. Willard,et al.  Cloning of human androgen receptor complementary DNA and localization to the X chromosome. , 1988, Science.

[168]  G. Cunha Growth factors as mediators of androgen action during male urogenital development , 1996, The Prostate. Supplement.

[169]  T. Nemoto,et al.  Dimerization characteristics of the DNA- and steroid-binding domains of the androgen receptor , 1994, The Journal of Steroid Biochemistry and Molecular Biology.

[170]  F. S. French,et al.  Expression of recombinant androgen receptor in cultured mammalian cells. , 1990, Molecular endocrinology.

[171]  J. Schneider Conversion of desoxycorticosterone to four allopregnane metabolites by rat liver in vitro. , 1952, The Journal of biological chemistry.

[172]  G. Jenster,et al.  Changes in the abundance of androgen receptor isotypes: effects of ligand treatment, glutamine-stretch variation, and mutation of putative phosphorylation sites. , 1994, Biochemistry.

[173]  J. Isaacs,et al.  Changes in dihydrotestosterone metabolism and the development of benign prostatic hyperplasia in the aging beagle. , 1983, Journal of steroid biochemistry.

[174]  N. Orentreich,et al.  Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. , 1992, The Journal of clinical endocrinology and metabolism.

[175]  D. S. Coffey,et al.  Human androgen receptor binding to the androgen response element of prostate specific antigen. , 1994, Journal of andrology.

[176]  D. Dp,et al.  Quantitative determination of prostatic epithelial and stromal hyperplasia by a new technique. Biomorphometrics. , 1978 .

[177]  F. S. French,et al.  Androgen receptor defects : Historical, clinical, and molecular perspectives , 1995 .

[178]  R. Weinshilboum,et al.  Human dehydroepiandrosterone sulfotransferase pharmacogenetics: Quantitative Western analysis and gene sequence polymorphisms , 1996, The Journal of Steroid Biochemistry and Molecular Biology.

[179]  G. Prins,et al.  Androgen receptor distribution in rat testis: new implications for androgen regulation of spermatogenesis. , 1994, Endocrinology.

[180]  N. Chamberlain,et al.  The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. , 1994, Nucleic acids research.

[181]  K. Yamamoto,et al.  Two signals mediate hormone‐dependent nuclear localization of the glucocorticoid receptor. , 1987, The EMBO journal.

[182]  Heiko,et al.  Transcriptional and posttranscriptional regulation of human androgen receptor expression by androgen. , 1993, Molecular endocrinology.

[183]  J. Gustafsson,et al.  Cloning of a novel receptor expressed in rat prostate and ovary. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[184]  T. Brown,et al.  Identification and Characterization of a Novel Androgen Response Element Composed of a Direct Repeat* , 1997, The Journal of Biological Chemistry.

[185]  E. Milgrom,et al.  Mechanisms of nuclear localization of the progesterone receptor: Evidence for interaction between monomers , 1989, Cell.

[186]  Jean D. Wilson Role of dihydrotestosterone in androgen action , 1996, The Prostate. Supplement.

[187]  T. Meyer,et al.  Cyclic adenosine 3',5'-monophosphate response element binding protein (CREB) and related transcription-activating deoxyribonucleic acid-binding proteins. , 1993, Endocrine reviews.

[188]  N. Kyprianou,et al.  Programmed cell death as a new target for prostatic cancer therapy. , 1991, Cancer surveys.

[189]  S. Liao,et al.  Steroid structure and androgenic activity. Specificities involved in the receptor binding and nuclear retention of various androgens. , 1973, The Journal of biological chemistry.

[190]  J. Imperato-McGinley,et al.  C19 and C21 5β/5α Metabolite Ratios in Subjects Treated with the 5α-Reductase Inhibitor Finasteride: Comparison of Male Pseudohermaphrodites with Inherited 5α-Reductase Deficiency* , 1990 .

[191]  M. Gleave,et al.  Androgenic Induction of Prostate-specific Antigen Gene Is Repressed by Protein-Protein Interaction between the Androgen Receptor and AP-1/c-Jun in the Human Prostate Cancer Cell Line LNCaP* , 1997, The Journal of Biological Chemistry.

[192]  M. Montminy,et al.  Role of CBP/P300 in nuclear receptor signalling , 1996, Nature.

[193]  J. A. van der Korput,et al.  Structural organization of the human androgen receptor gene. , 1989, Journal of molecular endocrinology.

[194]  J. Morley,et al.  Biological actions of androgens. , 1987, Endocrine reviews.

[195]  P. C. Supakar,et al.  Functional role of a conformationally flexible homopurine/homopyrimidine domain of the androgen receptor gene promoter interacting with Sp1 and a pyrimidine single strand DNA-binding protein. , 1997, Molecular endocrinology.

[196]  N. Kyprianou,et al.  Activation of programmed cell death in the rat ventral prostate after castration. , 1988, Endocrinology.

[197]  E. Baulieu,et al.  AN ADRENAL-SECRETED "ANDROGEN": DEHYDROISOANDROSTERONE SULFATE. ITS METABOLISM AND A TENTATIVE GENERALIZATION ON THE METABOLISM OF OTHER STEROID CONJUGATES IN MAN. , 1965, Recent progress in hormone research.

[198]  M. Mancini,et al.  Age-dependent reversal of the lobular distribution of androgen-inducible alpha 2u globulin and androgen-repressible SMP-2 in rat liver. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[199]  E. Gurpide Enzymatic modulation of hormonal action at the target tissue. , 1978, Journal of toxicology and environmental health.

[200]  E. Wilson,et al.  Androgen receptor phosphorylation, turnover, nuclear transport, and transcriptional activation. Specificity for steroids and antihormones. , 1992, The Journal of biological chemistry.

[201]  B. Furr Casodex: Preclinical Studies and Controversies a , 1995, Annals of the New York Academy of Sciences.

[202]  F. S. French,et al.  The human androgen receptor: complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. , 1988, Molecular endocrinology.

[203]  G. Martin,et al.  Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. , 1994, Science.

[204]  L. Chung,et al.  Hormone-induced morphogenesis and growth: role of mesenchymal-epithelial interactions. , 1983, Recent progress in hormone research.

[205]  W. Tilley,et al.  Expression of the human androgen receptor gene utilizes a common promoter in diverse human tissues and cell lines. , 1990, The Journal of biological chemistry.

[206]  G. Hager,et al.  Transcriptional Regulation of Mammalian Genes in Vivo , 1997, The Journal of Biological Chemistry.

[207]  D. Russell,et al.  Steroid 5α-Reductase 2 Deficiency , 1993 .

[208]  R. Hobkirk Steroid sulfation Current concepts , 1993, Trends in Endocrinology & Metabolism.

[209]  D. Tindall,et al.  The Androgen Receptor Is Transcriptionally Suppressed by Proteins That Bind Single-stranded DNA (*) , 1995, The Journal of Biological Chemistry.

[210]  G. Jenster,et al.  Functional domains of the human androgen receptor , 1992, The Journal of Steroid Biochemistry and Molecular Biology.